Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Trading Statement

12 Oct 2016 07:00

RNS Number : 2713M
Scapa Group PLC
12 October 2016
 

 

12 October 2016

 

 

 

Scapa Group plc ("Scapa" or "the Group")

 

Period end update

 

Scapa Group plc (AIM: SCPA), a global supplier of bonding solutions and manufacturer of adhesive based products for the Healthcare and Industrial markets, is today providing a period end update for the six months ended 30 September 2016.

 

Group revenue, trading profits* and margins are all ahead of last year. The Group has benefitted from recent favourable currency movements and better than expected operational efficiency. The integration of EuroMed, acquired in May 2016, is on track and progressing well. We remain confident of strong progress for the year.

 

The Group expects to release its results for the half year on 22 November 2016.

 

 

*Before exceptional items, amortisation of intangible assets and legacy pensions costs and finance charges

 

 

Enquiries:

Scapa Group plc

Heejae Chae - Chief Executive

Graham Hardcastle - Finance Director

 

 

0161 301 7430

 

Numis Securities Limited

(Nominated Adviser)

Mark Lander / Richard Thomas

 

 

 

 

020 7260 1000

 

Berenberg

(Joint Broker)

Chris Bowman / Amritha Murali

 

Weber Shandwick

Nick Oborne

 

 

 

 

020 3207 7800

 

 

020 7067 0721

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKDDQPBDDOKD
Date   Source Headline
23rd Dec 20143:48 pmRNSHolding(s) in Company
10th Dec 20141:09 pmRNSHolding(s) in Company
2nd Dec 201410:00 amRNSDirectorate Change
1st Dec 201410:07 amRNSHolding(s) in Company
1st Dec 201410:03 amRNSHolding(s) in Company
26th Nov 20142:09 pmRNSAdditional Listing
25th Nov 20147:00 amRNSHalf Yearly Report
24th Nov 20149:08 amRNSHolding(s) in Company
18th Nov 20149:27 amRNSHolding(s) in Company
29th Oct 20143:33 pmRNSHolding(s) in Company
9th Oct 20147:00 amRNSTrading Statement
11th Aug 20147:00 amRNSDirector/PDMR Shareholding
7th Aug 20147:00 amRNSBlocklisting Interim Review
6th Aug 20149:03 amRNSDirector/PDMR Shareholding
23rd Jul 20147:00 amRNSDirector/PDMR Shareholding
22nd Jul 20145:04 pmRNSHolding(s) in Company
22nd Jul 20147:00 amRNSAGM Statement
11th Jun 20147:00 amRNSCompany Listing
9th Jun 20147:00 amRNSDirector/PDMR Shareholding
30th May 20143:44 pmRNSHolding(s) in Company
28th May 20147:00 amRNSFinal Results
16th May 20149:29 amRNSHolding(s) in Company
13th May 20143:08 pmRNSHolding(s) in Company
28th Apr 20144:20 pmRNSHolding(s) in Company-AMENDMENT
25th Apr 20142:58 pmRNSHolding(s) in Company
11th Apr 20149:45 amRNSHolding(s) in Company
10th Apr 20147:00 amRNSTrading Statement
3rd Apr 201410:24 amRNSAdditional Listing
13th Mar 20145:17 pmRNSHolding(s) in Company
12th Mar 20142:31 pmRNSAdditional Listing
6th Mar 20149:23 amRNSHolding(s) in Company
3rd Mar 20141:11 pmRNSHolding(s) in Company
18th Feb 20143:52 pmRNSHolding(s) in Company
7th Feb 20147:00 amRNSBlocklisting Interim Review
6th Feb 20147:00 amRNSMerger of UK Pension Schemes
29th Jan 20147:00 amRNSNew Finance Facility
9th Jan 20149:12 amRNSHolding(s) in Company
20th Dec 20138:42 amRNSHolding(s) in Company
11th Dec 20135:21 pmRNSHolding(s) in Company
11th Dec 20137:00 amRNSDirector/PDMR Shareholding
10th Dec 20137:00 amRNSDirector/PDMR Shareholding
26th Nov 20137:00 amRNSHalf Yearly Report
25th Nov 20134:09 pmRNSHolding(s) in Company
5th Nov 201312:11 pmRNSHolding(s) in Company
10th Oct 20137:00 amRNSTrading Statement
27th Sep 20137:00 amRNSHolding(s) in Company
7th Aug 20134:52 pmRNSHolding(s) in Company
7th Aug 20138:57 amRNSBlocklisting Interim Review
26th Jul 20138:47 amRNSHolding(s) in Company
26th Jul 20138:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.